Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02534623Unknown
Randomised, open-label trial of bupivacaine, propofol and sevoflurane in bladder cancer (2 arms), sponsored by Opća Bolnica Zadar. Primary endpoint: Quality of Recovery 40 at 24 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02534623.